KUN YUN

Dr. KUN YUN


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
MKmyungheeq kim
myungheeq kim
PTPhuong Tran
Phuong Tran
KYKUN YUN
KUN YUN
JSJungbin Song
Jungbin Song
HKHocheol Kim
Hocheol Kim
Benign prostatic hyperplasia (BPH) is the most common condition in elderly men that is characterized by an increase in the size of the prostate gland. Cinnamomum cassia and Rosa laevigata have been reported to treat the symptoms associated with BPH. The aim of this study was to evaluate the effects of HT080, an herbal extract of C. cassia and R. laevigata, on a testosterone propionate (TP)-induced BPH rat model. The rats received a daily subcutaneous injection of TP (3 mg/kg) for 4 weeks to induce BPH. Rats were divided into four groups: group 1 (sham), group 2 (BPH, TP alone), group 3 (Fina, TP + finasteride 1 mg/kg/day), and group 4 (HT080, TP + HT080 200 mg/kg/day). At the end of the experiment, all rats were sacrificed, and their prostate glands were removed, weighed, and subjected to histopathological examination and western blot analyses. Serum testosterone and dihydrotestosterone (DHT) levels were determined. In addition, serum alanine and aspartate aminotransferase levels were measured to evaluate the toxicity in the liver. The Hershberger bioassay was also conducted to investigate the effects of HT080 on androgenic and antiandrogenic activities. In the BPH model, the prostate weight, prostate index, prostate epithelial thickness, and serum testosterone and DHT levels in the HT080 group were significantly reduced compared to the BPH group. Histological studies showed that HT080 reduced prostatic hyperplasia. The protein expression of androgen receptor from the HT080 group was significantly reduced in comparison with the BPH group (p < 0.05). HT080 also induced apoptosis by regulating Bcl-2 and Bax expression. In addition, HT080 showed no toxicity in the liver and did not exhibit androgenic and antiandrogenic activities. Our finding revealed that HT080 can be a potential candidate for the treatment of BPH by regulating androgen receptor signaling and apoptosis.

13 February 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
SKSe-Young Kim
Se-Young Kim
MKMinju Kim
Minju Kim
YCYoung-Woong Choi
Young-Woong Choi
MKMi-Yeon Kim
Mi-Yeon Kim
KYKUN YUN
KUN YUN
HKHocheol Kim
Hocheol Kim
Background: Obesity is one of the most prevalent metabolic disorders worldwide, and its long-term management remains challenging due to the limited efficacy and adverse effects of current pharmacological treatments. Accordingly, there is growing interest in safe and effective anti-obesity strategies based on natural compounds. This study aimed to evaluate the anti-obesity effects of HT099, an extract derived from Prunus persica (peach blossom), and to investigate molecular changes associated with its metabolic effects in a high-fat diet (HFD)-induced obesity mouse model. Methods: Male C57BL/6N mice were fed an HFD and orally administered HT099 (50 or 100 mg/kg) or the positive control orlistat (40 mg/kg) for 12 weeks. Body weight, adipose tissue accumulation, food efficiency ratio, glucose tolerance, serum lipid profiles, and hepatic gene expression related to lipid metabolism were evaluated. Results: HT099 supplementation significantly attenuated body weight gain and reduced white adipose tissue accumulation while improving food efficiency ratio. HT099 also ameliorated HFD-induced glucose intolerance and favorably modulated serum lipid profiles, including reduced triglyceride levels, increased HDL-cholesterol levels, and improved non-HDL cholesterol indices. At the molecular level, HT099 administration was associated with an increased hepatic AMPKα1 mRNA expression and decreased expression of adipogenic and lipogenic genes, including C/EBPα, PPARγ, FAS, and SREBP-1c. Conclusions: These findings indicate that HT099 exerts anti-obesity effects in HFD-induced obese mice, accompanied by improvements in lipid and glucose metabolism and changes in adipogenesis- and lipogenesis-related gene expression. Collectively, the results support the potential of HT099 as a natural bioactive agent for obesity management.